Merus Banner Image

Merus has reached its limit for free report views

Work for Merus? Upgrade Your Profile and unlock all your annual reports.


  • Ticker MRUS
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Merus Logo Image
  • 51-200 Employees
  • Based in Utrecht, Netherlands
Merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. Their most advanced development programs use the Biclonics® format. Biclonics® are capable of simultaneously attacking tumors in multiple ways. For example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways.
4.8 / 5.0 (106)

Merus reports have an aggregate usefulness score of 4.8 based on 106 reviews.


Most Recent Annual Report

MOST RECENT 2022 Annual Report and Form 10K

Report Locked. Merus has reached its limit for free report views.

Older/Archived Annual Reports

Merus Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!